Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metreleptin for Congenital Leptin Deficiency
NCT00657605Phase 2Completed
- Sponsor
- University of Miami
- Start
- Jun 2001
- Primary completion
- May 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of metreleptin in congenital leptin deficiency (CLD), sponsored by University of Miami. Started Jun 2001; status: completed.
02
Drugs
metreleptin
03
Conditions
congenital leptin deficiency (CLD)
Beyond the preview
Go deeper on NCT00657605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00657605.